Carcinoma of the oral pharynx

An analysis of subsite treatment heterogeneity

Ryan F. Osborne, Jimmy J. Brown

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

The data indicate that SCC of the various subsites of the oropharynx can be treated successfully with acceptable locoregional control and survival rates by using either surgery or primary radiotherapy for T1 or T2 primary lesions. Treatment success data for late-stage disease (T3 and T4) are less encouraging, regardless of which modality is used or which treatment center is administering treatment. This finding may suggest an intrinsic property of these lesions or the patient that may be going unnoticed. One problem is that the diversity of approaches to these lesions hinders any meaningful comparisons between series from different treatment centers. There exists heterogeneity in patient populations and approaches to staging and characterization of these diseases. This situation has ensured the same heterogeneity in treatment philosophy, which is largely institutionally based.

Original languageEnglish (US)
Pages (from-to)71-80
Number of pages10
JournalSurgical Oncology Clinics of North America
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Pharynx
Carcinoma
Therapeutics
Oropharynx
Radiotherapy
Survival Rate
Population

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Carcinoma of the oral pharynx : An analysis of subsite treatment heterogeneity. / Osborne, Ryan F.; Brown, Jimmy J.

In: Surgical Oncology Clinics of North America, Vol. 13, No. 1, 01.01.2004, p. 71-80.

Research output: Contribution to journalReview article

@article{df2e70cb27ff4513aa45f3d63d173ba1,
title = "Carcinoma of the oral pharynx: An analysis of subsite treatment heterogeneity",
abstract = "The data indicate that SCC of the various subsites of the oropharynx can be treated successfully with acceptable locoregional control and survival rates by using either surgery or primary radiotherapy for T1 or T2 primary lesions. Treatment success data for late-stage disease (T3 and T4) are less encouraging, regardless of which modality is used or which treatment center is administering treatment. This finding may suggest an intrinsic property of these lesions or the patient that may be going unnoticed. One problem is that the diversity of approaches to these lesions hinders any meaningful comparisons between series from different treatment centers. There exists heterogeneity in patient populations and approaches to staging and characterization of these diseases. This situation has ensured the same heterogeneity in treatment philosophy, which is largely institutionally based.",
author = "Osborne, {Ryan F.} and Brown, {Jimmy J.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/S1055-3207(03)00117-0",
language = "English (US)",
volume = "13",
pages = "71--80",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Carcinoma of the oral pharynx

T2 - An analysis of subsite treatment heterogeneity

AU - Osborne, Ryan F.

AU - Brown, Jimmy J.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - The data indicate that SCC of the various subsites of the oropharynx can be treated successfully with acceptable locoregional control and survival rates by using either surgery or primary radiotherapy for T1 or T2 primary lesions. Treatment success data for late-stage disease (T3 and T4) are less encouraging, regardless of which modality is used or which treatment center is administering treatment. This finding may suggest an intrinsic property of these lesions or the patient that may be going unnoticed. One problem is that the diversity of approaches to these lesions hinders any meaningful comparisons between series from different treatment centers. There exists heterogeneity in patient populations and approaches to staging and characterization of these diseases. This situation has ensured the same heterogeneity in treatment philosophy, which is largely institutionally based.

AB - The data indicate that SCC of the various subsites of the oropharynx can be treated successfully with acceptable locoregional control and survival rates by using either surgery or primary radiotherapy for T1 or T2 primary lesions. Treatment success data for late-stage disease (T3 and T4) are less encouraging, regardless of which modality is used or which treatment center is administering treatment. This finding may suggest an intrinsic property of these lesions or the patient that may be going unnoticed. One problem is that the diversity of approaches to these lesions hinders any meaningful comparisons between series from different treatment centers. There exists heterogeneity in patient populations and approaches to staging and characterization of these diseases. This situation has ensured the same heterogeneity in treatment philosophy, which is largely institutionally based.

UR - http://www.scopus.com/inward/record.url?scp=1542357318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542357318&partnerID=8YFLogxK

U2 - 10.1016/S1055-3207(03)00117-0

DO - 10.1016/S1055-3207(03)00117-0

M3 - Review article

VL - 13

SP - 71

EP - 80

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -